| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INMB | Common Stock | Sale | $117,117 | -5,850 | -0.39% | $20.02 | 1,500,401 | 07 Jul 2021 | Direct | F1, F2 |
| transaction | INMB | Common Stock | Sale | $487,588 | -24,150 | -1.6% | $20.19 | 1,476,251 | 08 Jul 2021 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.00 to $20.04, inclusive. The Reporting Person undertakes to provide to Inmune Bio, Inc., any security holder of Inmune Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.00 to $20.48, inclusive. The Reporting Person undertakes to provide to Inmune Bio, Inc., any security holder of Inmune Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the range set forth above. |